Japan's medical device market, positioned as the world's second-largest, is poised for significant growth in the coming years. With a projected increase from $54.5 billion in 2018 to $74.7 billion in 2025, representing a CAGR of 4.6 percent, Japan offers a promising landscape for healthcare investments. Factors such as an aging population, a rise in patients with chronic and lifestyle diseases, comprehensive health insurance coverage, and favorable regulatory measures contribute to the country's appeal for medical device innovation.
To foster further development, the Japanese government has implemented initiatives aimed at streamlining the regulatory approval review process and expediting the introduction of innovative medical products. As a result, Japan presents a supportive environment for the development and introduction of improved medical solutions, creating opportunities for both domestic and international stakeholders in the healthcare sector.
The aging population in Japan presents challenges in terms of reworking the reimbursement system and addressing the potential negative consequences caused by a shrinking tax base due to a lack of young population. These factors, combined with rising inflation, create a pressing and increasingly difficult situation for the industry. Despite the abundance of opportunities in the sector, consumers face significant challenges, including delays in accessing medical devices, which directly impact individuals enduring physical pain.
Furthermore, there is limited availability of diverse instrument options to effectively address their specific ailments, exacerbating the difficulties faced by these consumers. Hoya Technosurgical, a leading company in the industry, is committed to addressing these challenges by prioritizing the needs of patients and surgeons. The firm’s primary objective is to minimize healing time for fractures by providing a comprehensive range of products and designs to effectively treat a wide variety of fracture types.
Journey Since Inception
Hoya Technosurgical, formed through the merger of Nihon Unitech and part of Pentax, has become a leading player in the medical device industry. Pentax's pioneering work on hydroxyapatite as an artificial bone void filler and chromatography resin set the stage for a strong business presence. Hoya Corporation acquired Pentax in 2008 and, recognizing the growth potential for the hydroxyapatite business, strategically expanded further in orthopedic surgery by acquiring Nihon Unitech, a manufacturer of titanium trauma implants, in 2012. Merging the artificial bone void filler business with Nihon Unitech in 2013, Hoya Technosurgical emerged as a powerful force in the market.
Leveraging its expertise in artificial bone void fillers, Hoya Technosurgical swiftly grew the trauma business, particularly excelling in treating distal radius fractures and trochanteric hip fractures. While primarily focused on the domestic market, the company has made inroads into other Asian countries through strategic distributor partnerships, meeting the demand for artificial bone void fillers and surgical loupes.
“Hoya Technosurgical is one of the top Japanese companies in the orthopedics field, leading the market in artificial bone void fillers and fourth in the market for trauma implants. We have achieved strong growth through the introduction of new products, and hope to provide more patients with relief in Japan and around the world in the future. We seek new strategic partners and collaborators to further accelerate our drive to promote innovation and bring to light new opportunities for all stakeholders”, shares Yasuyuki Nitta, President & CEO of Hoya Technosurgical.
In addition to its success in the medical device sector, Hoya Technosurgical's chromatography business has experienced remarkable growth. Through collaboration with Bio-Rad, the firm has established a global presence in
the chromatography market, delivering innovative solutions to researchers and scientists worldwide.
Flagship Services
Hoya Technosurgical leads the market in Japan with its exceptional range of artificial bone void fillers, offering solutions for various indications and anatomical areas. Setting itself apart from competitors, the company differentiates the range of products through the provision of procedure-specific kits and combinations with metal implants, in addition to traditional types of fillers.
In the realm of trauma implants, Hoya Technosurgical continues to stand out by offering a diverse array of variations. This approach allows surgeons to select the most suitable radius plates and hip nail systems that precisely fit the fracture area and type, ensuring optimal outcomes for patients. Leveraging the team’s expertise in orthopedic surgery, particularly in trauma and spine procedures, the company further enhances its offerings through the fusion of metal implants with its proprietary artificial bone technology. This strategic combination capitalizes on Hoya Technosurgical’s strengths and reinforces the commitment to delivering innovative solutions in the field.
Hoya technosurgical leverages japan's robust talent pool in science & engineering, attracting professionals with extensive market knowledge
With a focus on customization and meeting the unique needs of healthcare professionals, Hoya Technosurgical is dedicated to advancing the field of orthopedic surgery. Through these flagship services and commitment to innovation, Hoya Technosurgical continues to solidify its position as a trusted partner in the medical device industry, shaping the future of orthopedic surgery and contributing to the advancement of healthcare as a whole.
To further ensure differentiation from competitors, the company manufactures its range of offerings in-house which also provides an advantage for quality assurance. “The majority of our products are manufactured in-house in Japan, including all of our artificial bone void fillers and our distal radius fracture implants. We apply a wide range of harmonized standards and guidelines to safety and performance and strive to be 'state-of-the-art' in our approach to quality. We also consider the provision of solutions to unmet needs as part of our quality, and place great importance on communication with medical professionals”, further shares Takaaki Maeda, Head of Regulatory Affairs & Quality Assurance.
Expertise & Approach
Hoya Technosurgical leverages Japan's robust talent pool in science and engineering, attracting professionals with extensive market knowledge. The company actively promotes career hires who possess a deep understanding of the industry. To foster innovation, Hoya Technosurgical has recently intensified its focus on international capabilities, diversifying the team and introducing fresh perspectives. This diversity stimulates creativity and offers valuable insights into potential global expansion. Furthermore, as part of the Hoya Corporation, Hoya Technosurgical benefits from access to a global pool of talent and technical expertise. This enables the seamless sharing of resources and knowledge across subsidiaries, enhancing the company's overall capabilities.
Hoya Technosurgical's dedicated sales and marketing experts maintain effective communication channels with physicians allowing the company to actively understand physicians' needs and preferences, and showcasing how their products can address those requirements. In order to ensure the necessary instruments for implant surgeries, Hoya Technosurgical incorporates a rigorous manufacturing process.
“Our R&D processes have incorporated a modified version of agile development and concurrent engineering, with which we hope to further improve the efficiency and efficacy of our innovation efforts. We are also continuously working to strengthen our quality assurance and manufacturing processes to meet the demands of the market. We work together with our sister companies in the Hoya organization to learn from their research capabilities and technologies to inspire new innovation at Hoya Technosurgical”, further adds Charles Graffam, Head of Corporate Development.
Future Roadmap
This year, Hoya Technosurgical has exciting plans for product launches in Japan. Upcoming releases by the company include innovative variations within the trochanteric hip fracture portfolio, leveraging the synergies between artificial bone void fillers and titanium implants. Simultaneously, the firm is actively pursuing opportunities to expand its presence to international markets. With a focus on maintaining the commitment to quality, Hoya Technosurgical aims to secure approvals for its exceptional products and establish fruitful collaborations with potential commercial partners overseas.
With a rich heritage, strategic acquisitions, and a commitment to innovation, Hoya Technosurgical continues to shape the medical device industry, providing cutting-edge products and driving advancements in healthcare globally.
Yasuyuki Nitta, CEO & President
Yasuyuki Nitta entered HOYA Corporation in 1990. In 2005, he was put in charge of Corporate Planning for Asia and Oceania in the Vision Care business segment, and in 2007, he moved to China, and in 2009, he was made the President and CEO of the China business. He restructured the China business for expansion, established a new business through a joint venture, and concluded the M&A of a Chinese manufacturer.
In 2012, he engaged in business expansion in emerging markets such as China and India, as well as Oceania as the head of the Asia and Oceania business. In 2017, he was installed as the CEO and President of HOYA Technosurgical.
.jpg "Technology in Cancer Care: A story of evolving paradigms")
.jpg "Bringing Shop Floor to Manufacturer's palm: Smart Factory Solutions for tomorrow")
